Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Valeant Pharmaceuticals International, a multinational specialty pharmaceutical company, has acquired Coria Laboratories, a privately-held specialty pharmaceutical company focused on dermatology products in the US.
Subscribe to our email newsletter
Under the terms of the agreement, Valeant purchased all of the outstanding shares of Coria from parent company, DFB Pharmaceuticals, and other shareholders for $95 million.